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For many years, a traditional event at hospitals
throughout the United States has been the convening of
intermittent conferences that serve as formats for discuss-
ing patient cancer management. These conferences have
been generally associated with appropriate gustatory
delights to further the attraction of these meetings. Gen-
erally a moderator has been responsible for developing the
case list utilizing recent patients diagnosed or treated at the
hospital. Because the desire to include the multidisciplin-
ary concept (surgery, radiation oncology, and medical
oncology) of cancer management has driven the case
selection, a potpourri of case presentations has been the
goal to create cross-cultural dialogue and encourage
participation.
It has been my pleasure to attend many of these cancer
conferences as a surveyor for the Accreditation (formally
‘‘Approvals’’) Program of the Commission on Cancer of
the American College of Surgeons. These conferences held
at small and medium-sized community hospitals, medical
school-associated teaching hospitals, and National Cancer
Institute-designated institutions are as diverse as the
institutions involved. Some include crisp PowerPoint pre-
sentations of only three or four patients. Other formats
include 10, 15, or more patients in an attempt to blend
education along with clinical management.
My issue with most of these conferences is that they are
based on a ‘‘show and tell’’ mentality rather than serving as
treatment-planning conferences utilizing the expertise of
the participating multidisciplinary experts. It has been a
pleasure to see that more recently ‘‘organ-based’’ (breast,
hepatopancreaticobiliary, gastrointestinal) and ‘‘diseased-
based’’(sarcoma, melanoma) conferences have been
created to serve as true treatment-planning conferences that
facilitate decision making, especially in this era of neoad-
juvant therapy. This is truly the format that should be
supported—not the anachronistic approaches of the tradi-
tional hospital ‘‘tumor board.’’
In this issue of Annals, Wright et al. describe the prev-
alence of multidisciplinary cancer conferences (MCCs) in
the province of Ontario, Canada, and analyze the barriers to
the adoption of meaningful planning conferences.
1 General
surgeons throughout Ontario were queried about their
perceptions regarding MCC implementation. In reply to a
survey, a reasonable (44%) response was obtained, which
represented surgeons working in both community and
academic institutions. Only 52% of hospitals had MCCs,
which were held over a variety of frequencies ranging
from weekly to monthly. The majority of those surgeons
responding had positive responses favoring the educational
and collegial nature of these conferences.
The obvious lacuna in the study is the absence of any
data that indicates that patients who are discussed have
beneﬁted from these multidisciplinary enclaves. Although
published examples exist of cancer conference follow-up
that assess adherence to management recommendations,
these examples are few and the methodology to capture
these data are problematic.
2–4 Recent strategies by the
American College of Surgeons Commission on Cancer
have urged inclusion of published guidelines to serve as
benchmarks of multidisciplinary care at COC accredited
hospitals.
Aside from guideline overview, the ideal multidisci-
plinary cancer conference should include a meaningful
discussion of treatment options supported by evidenced-
base reports. Clinical staging should result from presenta-
tions of all relevant physical examination, imaging,
laboratory, and pathological assessments. From these data,
the clinical stage should be derived, which permits a log-
ical discussion of all treatment options. Appropriate
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and trial accrual. Ideally these conferences should be
organ- or disease-based and should incorporate all practi-
tioners who have a stake in that particular patient’s care.
No treatment should be initiated before discussion in a
multidisciplinary enclave.
Our Canadian brethren plan to use their study results to
push for inclusion of MCCs in the appropriate hospitals in
Ontario. The really challenging project is to craft a tem-
plate that would ensure a meaningful treatment outcome
for the patients presented. Although collegiality and edu-
cation are laudable goals, the traditional MCC, absent of
meaningful treatment planning, can no longer be our par-
adigm. The authors correctly invoke the importance of
teleconferencing, especially from academic centers, and I
personally believe this is a laudable goal.
Because one of the barriers to effective MCC in the
Canadian study is lack of administrative support, we would
do well to share this study with our administrative man-
agement teams. Quality management of our patients with
cancer begins with the full support of our administrators,
physicians, and all cancer care providers to maintain the
quest for ideal cancer treatment.
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